関連する実験動画

Updated: May 5, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.2K

90Y-FAPI-46 サルコマおよびその他の固体腫瘍における放射性薬剤療法: 更新されたコホート分析

Helena Lanzafame1,2, Ilektra A Mavroeidi2,3, Kim M Pabst4,2

  • 1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany; helena.lanzafame@uk-essen.de.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
|February 19, 2026
PubMed
まとめ

Y-FAP阻害剤 (FAPI) -46放射性薬剤による治療は,進行がんの患者,特にサルコマの患者において,好ましい安全性プロファイルを示しています. 疾患の安定化は,患者のほぼ半分で観察され,サルコマ治療におけるその役割を支持しました.

キーワード:
90Y-FAPI-46について放射線薬剤療法による放射線薬剤療法サルコマ (Sarcomas) とはテラノスティクス (Teranostics) とは

さらに関連する動画

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

1.6K
Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

1.2K

関連する概念動画

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K